1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Viral Pneumonia Treatment Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Ribavirin 1.2.3 Acyclovir 1.2.4 Ganciclovir 1.2.5 Others 1.3 Market by Application 1.3.1 Global Viral Pneumonia Treatment Drugs Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospital Pharmacies 1.3.3 Retail Pharmacies 1.3.4 Online Pharmacies 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Viral Pneumonia Treatment Drugs Market Perspective (2016-2027) 2.2 Viral Pneumonia Treatment Drugs Growth Trends by Regions 2.2.1 Viral Pneumonia Treatment Drugs Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Viral Pneumonia Treatment Drugs Historic Market Share by Regions (2016-2021) 2.2.3 Viral Pneumonia Treatment Drugs Forecasted Market Size by Regions (2022-2027) 2.3 Viral Pneumonia Treatment Drugs Industry Dynamic 2.3.1 Viral Pneumonia Treatment Drugs Market Trends 2.3.2 Viral Pneumonia Treatment Drugs Market Drivers 2.3.3 Viral Pneumonia Treatment Drugs Market Challenges 2.3.4 Viral Pneumonia Treatment Drugs Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Viral Pneumonia Treatment Drugs Players by Revenue 3.1.1 Global Top Viral Pneumonia Treatment Drugs Players by Revenue (2016-2021) 3.1.2 Global Viral Pneumonia Treatment Drugs Revenue Market Share by Players (2016-2021) 3.2 Global Viral Pneumonia Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Viral Pneumonia Treatment Drugs Revenue 3.4 Global Viral Pneumonia Treatment Drugs Market Concentration Ratio 3.4.1 Global Viral Pneumonia Treatment Drugs Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Viral Pneumonia Treatment Drugs Revenue in 2020 3.5 Viral Pneumonia Treatment Drugs Key Players Head office and Area Served 3.6 Key Players Viral Pneumonia Treatment Drugs Product Solution and Service 3.7 Date of Enter into Viral Pneumonia Treatment Drugs Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Viral Pneumonia Treatment Drugs Breakdown Data by Type 4.1 Global Viral Pneumonia Treatment Drugs Historic Market Size by Type (2016-2021) 4.2 Global Viral Pneumonia Treatment Drugs Forecasted Market Size by Type (2022-2027) 5 Viral Pneumonia Treatment Drugs Breakdown Data by Application 5.1 Global Viral Pneumonia Treatment Drugs Historic Market Size by Application (2016-2021) 5.2 Global Viral Pneumonia Treatment Drugs Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Viral Pneumonia Treatment Drugs Market Size (2016-2027) 6.2 North America Viral Pneumonia Treatment Drugs Market Size by Type 6.2.1 North America Viral Pneumonia Treatment Drugs Market Size by Type (2016-2021) 6.2.2 North America Viral Pneumonia Treatment Drugs Market Size by Type (2022-2027) 6.2.3 North America Viral Pneumonia Treatment Drugs Market Size by Type (2016-2027) 6.3 North America Viral Pneumonia Treatment Drugs Market Size by Application 6.3.1 North America Viral Pneumonia Treatment Drugs Market Size by Application (2016-2021) 6.3.2 North America Viral Pneumonia Treatment Drugs Market Size by Application (2022-2027) 6.3.3 North America Viral Pneumonia Treatment Drugs Market Size by Application (2016-2027) 6.4 North America Viral Pneumonia Treatment Drugs Market Size by Country 6.4.1 North America Viral Pneumonia Treatment Drugs Market Size by Country (2016-2021) 6.4.2 North America Viral Pneumonia Treatment Drugs Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Viral Pneumonia Treatment Drugs Market Size (2016-2027) 7.2 Europe Viral Pneumonia Treatment Drugs Market Size by Type 7.2.1 Europe Viral Pneumonia Treatment Drugs Market Size by Type (2016-2021) 7.2.2 Europe Viral Pneumonia Treatment Drugs Market Size by Type (2022-2027) 7.2.3 Europe Viral Pneumonia Treatment Drugs Market Size by Type (2016-2027) 7.3 Europe Viral Pneumonia Treatment Drugs Market Size by Application 7.3.1 Europe Viral Pneumonia Treatment Drugs Market Size by Application (2016-2021) 7.3.2 Europe Viral Pneumonia Treatment Drugs Market Size by Application (2022-2027) 7.3.3 Europe Viral Pneumonia Treatment Drugs Market Size by Application (2016-2027) 7.4 Europe Viral Pneumonia Treatment Drugs Market Size by Country 7.4.1 Europe Viral Pneumonia Treatment Drugs Market Size by Country (2016-2021) 7.4.2 Europe Viral Pneumonia Treatment Drugs Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Viral Pneumonia Treatment Drugs Market Size (2016-2027) 8.2 Asia-Pacific Viral Pneumonia Treatment Drugs Market Size by Type 8.2.1 Asia-Pacific Viral Pneumonia Treatment Drugs Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Viral Pneumonia Treatment Drugs Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Viral Pneumonia Treatment Drugs Market Size by Type (2016-2027) 8.3 Asia-Pacific Viral Pneumonia Treatment Drugs Market Size by Application 8.3.1 Asia-Pacific Viral Pneumonia Treatment Drugs Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Viral Pneumonia Treatment Drugs Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Viral Pneumonia Treatment Drugs Market Size by Application (2016-2027) 8.4 Asia-Pacific Viral Pneumonia Treatment Drugs Market Size by Region 8.4.1 Asia-Pacific Viral Pneumonia Treatment Drugs Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Viral Pneumonia Treatment Drugs Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Viral Pneumonia Treatment Drugs Market Size (2016-2027) 9.2 Latin America Viral Pneumonia Treatment Drugs Market Size by Type 9.2.1 Latin America Viral Pneumonia Treatment Drugs Market Size by Type (2016-2021) 9.2.2 Latin America Viral Pneumonia Treatment Drugs Market Size by Type (2022-2027) 9.2.3 Latin America Viral Pneumonia Treatment Drugs Market Size by Type (2016-2027) 9.3 Latin America Viral Pneumonia Treatment Drugs Market Size by Application 9.3.1 Latin America Viral Pneumonia Treatment Drugs Market Size by Application (2016-2021) 9.3.2 Latin America Viral Pneumonia Treatment Drugs Market Size by Application (2022-2027) 9.3.3 Latin America Viral Pneumonia Treatment Drugs Market Size by Application (2016-2027) 9.4 Latin America Viral Pneumonia Treatment Drugs Market Size by Country 9.4.1 Latin America Viral Pneumonia Treatment Drugs Market Size by Country (2016-2021) 9.4.2 Latin America Viral Pneumonia Treatment Drugs Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Viral Pneumonia Treatment Drugs Market Size (2016-2027) 10.2 Middle East & Africa Viral Pneumonia Treatment Drugs Market Size by Type 10.2.1 Middle East & Africa Viral Pneumonia Treatment Drugs Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Viral Pneumonia Treatment Drugs Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Viral Pneumonia Treatment Drugs Market Size by Type (2016-2027) 10.3 Middle East & Africa Viral Pneumonia Treatment Drugs Market Size by Application 10.3.1 Middle East & Africa Viral Pneumonia Treatment Drugs Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Viral Pneumonia Treatment Drugs Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Viral Pneumonia Treatment Drugs Market Size by Application (2016-2027) 10.4 Middle East & Africa Viral Pneumonia Treatment Drugs Market Size by Country 10.4.1 Middle East & Africa Viral Pneumonia Treatment Drugs Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Viral Pneumonia Treatment Drugs Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Roche 11.1.1 Roche Company Details 11.1.2 Roche Business Overview 11.1.3 Roche Viral Pneumonia Treatment Drugs Introduction 11.1.4 Roche Revenue in Viral Pneumonia Treatment Drugs Business (2016-2021) 11.1.5 Roche Recent Development 11.2 GlaxoSmithKline 11.2.1 GlaxoSmithKline Company Details 11.2.2 GlaxoSmithKline Business Overview 11.2.3 GlaxoSmithKline Viral Pneumonia Treatment Drugs Introduction 11.2.4 GlaxoSmithKline Revenue in Viral Pneumonia Treatment Drugs Business (2016-2021) 11.2.5 GlaxoSmithKline Recent Development 11.3 Pfizer 11.3.1 Pfizer Company Details 11.3.2 Pfizer Business Overview 11.3.3 Pfizer Viral Pneumonia Treatment Drugs Introduction 11.3.4 Pfizer Revenue in Viral Pneumonia Treatment Drugs Business (2016-2021) 11.3.5 Pfizer Recent Development 11.4 Novartis 11.4.1 Novartis Company Details 11.4.2 Novartis Business Overview 11.4.3 Novartis Viral Pneumonia Treatment Drugs Introduction 11.4.4 Novartis Revenue in Viral Pneumonia Treatment Drugs Business (2016-2021) 11.4.5 Novartis Recent Development 11.5 Johnson and Johnson 11.5.1 Johnson and Johnson Company Details 11.5.2 Johnson and Johnson Business Overview 11.5.3 Johnson and Johnson Viral Pneumonia Treatment Drugs Introduction 11.5.4 Johnson and Johnson Revenue in Viral Pneumonia Treatment Drugs Business (2016-2021) 11.5.5 Johnson and Johnson Recent Development 11.6 Teva Pharmaceutical 11.6.1 Teva Pharmaceutical Company Details 11.6.2 Teva Pharmaceutical Business Overview 11.6.3 Teva Pharmaceutical Viral Pneumonia Treatment Drugs Introduction 11.6.4 Teva Pharmaceutical Revenue in Viral Pneumonia Treatment Drugs Business (2016-2021) 11.6.5 Teva Pharmaceutical Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Viral Pneumonia Treatment Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Ribavirin Table 3. Key Players of Acyclovir Table 4. Key Players of Ganciclovir Table 5. Key Players of Others Table 6. Global Viral Pneumonia Treatment Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Viral Pneumonia Treatment Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Viral Pneumonia Treatment Drugs Market Size by Regions (2016-2021) & (US$ Million) Table 9. Global Viral Pneumonia Treatment Drugs Market Share by Regions (2016-2021) Table 10. Global Viral Pneumonia Treatment Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 11. Global Viral Pneumonia Treatment Drugs Market Share by Regions (2022-2027) Table 12. Viral Pneumonia Treatment Drugs Market Trends Table 13. Viral Pneumonia Treatment Drugs Market Drivers Table 14. Viral Pneumonia Treatment Drugs Market Challenges Table 15. Viral Pneumonia Treatment Drugs Market Restraints Table 16. Global Viral Pneumonia Treatment Drugs Revenue by Players (2016-2021) & (US$ Million) Table 17. Global Viral Pneumonia Treatment Drugs Market Share by Players (2016-2021) Table 18. Global Top Viral Pneumonia Treatment Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Viral Pneumonia Treatment Drugs as of 2020) Table 19. Ranking of Global Top Viral Pneumonia Treatment Drugs Companies by Revenue (US$ Million) in 2020 Table 20. Global 5 Largest Players Market Share by Viral Pneumonia Treatment Drugs Revenue (CR5 and HHI) & (2016-2021) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Viral Pneumonia Treatment Drugs Product Solution and Service Table 23. Date of Enter into Viral Pneumonia Treatment Drugs Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Viral Pneumonia Treatment Drugs Market Size by Type (2016-2021) (US$ Million) Table 26. Global Viral Pneumonia Treatment Drugs Revenue Market Share by Type (2016-2021) Table 27. Global Viral Pneumonia Treatment Drugs Forecasted Market Size by Type (2022-2027) (US$ Million) Table 28. Global Viral Pneumonia Treatment Drugs Revenue Market Share by Type (2022-2027) & (US$ Million) Table 29. Global Viral Pneumonia Treatment Drugs Market Size Share by Application (2016-2021) & (US$ Million) Table 30. Global Viral Pneumonia Treatment Drugs Revenue Market Share by Application (2016-2021) Table 31. Global Viral Pneumonia Treatment Drugs Forecasted Market Size by Application (2022-2027) (US$ Million) Table 32. Global Viral Pneumonia Treatment Drugs Revenue Market Share by Application (2022-2027) & (US$ Million) Table 33. North America Viral Pneumonia Treatment Drugs Market Size by Type (2016-2021) (US$ Million) Table 34. North America Viral Pneumonia Treatment Drugs Market Size by Type (2022-2027) & (US$ Million) Table 35. North America Viral Pneumonia Treatment Drugs Market Size by Application (2016-2021) (US$ Million) Table 36. North America Viral Pneumonia Treatment Drugs Market Size by Application (2022-2027) & (US$ Million) Table 37. North America Viral Pneumonia Treatment Drugs Market Size by Country (2016-2021) & (US$ Million) Table 38. North America Viral Pneumonia Treatment Drugs Market Size by Country (2022-2027) & (US$ Million) Table 39. Europe Viral Pneumonia Treatment Drugs Market Size by Type (2016-2021) (US$ Million) Table 40. Europe Viral Pneumonia Treatment Drugs Market Size by Type (2022-2027) & (US$ Million) Table 41. Europe Viral Pneumonia Treatment Drugs Market Size by Application (2016-2021) (US$ Million) Table 42. Europe Viral Pneumonia Treatment Drugs Market Size by Application (2022-2027) & (US$ Million) Table 43. Europe Viral Pneumonia Treatment Drugs Market Size by Country (2016-2021) & (US$ Million) Table 44. Europe Viral Pneumonia Treatment Drugs Market Size by Country (2022-2027) & (US$ Million) Table 45. Asia-Pacific Viral Pneumonia Treatment Drugs Market Size by Type (2016-2021) (US$ Million) Table 46. Asia-Pacific Viral Pneumonia Treatment Drugs Market Size by Type (2022-2027) & (US$ Million) Table 47. Asia-Pacific Viral Pneumonia Treatment Drugs Market Size by Application (2016-2021) (US$ Million) Table 48. Asia-Pacific Viral Pneumonia Treatment Drugs Market Size by Application (2022-2027) & (US$ Million) Table 49. Asia-Pacific Viral Pneumonia Treatment Drugs Market Size by Region (2016-2021) & (US$ Million) Table 50. Asia-Pacific Viral Pneumonia Treatment Drugs Market Size by Region (2022-2027) & (US$ Million) Table 51. Latin America Viral Pneumonia Treatment Drugs Market Size by Type (2016-2021) (US$ Million) Table 52. Latin America Viral Pneumonia Treatment Drugs Market Size by Type (2022-2027) & (US$ Million) Table 53. Latin America Viral Pneumonia Treatment Drugs Market Size by Application (2016-2021) (US$ Million) Table 54. Latin America Viral Pneumonia Treatment Drugs Market Size by Application (2022-2027) & (US$ Million) Table 55. Latin America Viral Pneumonia Treatment Drugs Market Size by Country (2016-2021) & (US$ Million) Table 56. Latin America Viral Pneumonia Treatment Drugs Market Size by Country (2022-2027) & (US$ Million) Table 57. Middle East & Africa Viral Pneumonia Treatment Drugs Market Size by Type (2016-2021) (US$ Million) Table 58. Middle East & Africa Viral Pneumonia Treatment Drugs Market Size by Type (2022-2027) & (US$ Million) Table 59. Middle East & Africa Viral Pneumonia Treatment Drugs Market Size by Application (2016-2021) (US$ Million) Table 60. Middle East & Africa Viral Pneumonia Treatment Drugs Market Size by Application (2022-2027) & (US$ Million) Table 61. Middle East & Africa Viral Pneumonia Treatment Drugs Market Size by Country (2016-2021) & (US$ Million) Table 62. Middle East & Africa Viral Pneumonia Treatment Drugs Market Size by Country (2022-2027) & (US$ Million) Table 63. Roche Company Details Table 64. Roche Business Overview Table 65. Roche Viral Pneumonia Treatment Drugs Product Table 66. Roche Revenue in Viral Pneumonia Treatment Drugs Business (2016-2021) & (US$ Million) Table 67. Roche Recent Development Table 68. GlaxoSmithKline Company Details Table 69. GlaxoSmithKline Business Overview Table 70. GlaxoSmithKline Viral Pneumonia Treatment Drugs Product Table 71. GlaxoSmithKline Revenue in Viral Pneumonia Treatment Drugs Business (2016-2021) & (US$ Million) Table 72. GlaxoSmithKline Recent Development Table 73. Pfizer Company Details Table 74. Pfizer Business Overview Table 75. Pfizer Viral Pneumonia Treatment Drugs Product Table 76. Pfizer Revenue in Viral Pneumonia Treatment Drugs Business (2016-2021) & (US$ Million) Table 77. Pfizer Recent Development Table 78. Novartis Company Details Table 79. Novartis Business Overview Table 80. Novartis Viral Pneumonia Treatment Drugs Product Table 81. Novartis Revenue in Viral Pneumonia Treatment Drugs Business (2016-2021) & (US$ Million) Table 82. Novartis Recent Development Table 83. Johnson and Johnson Company Details Table 84. Johnson and Johnson Business Overview Table 85. Johnson and Johnson Viral Pneumonia Treatment Drugs Product Table 86. Johnson and Johnson Revenue in Viral Pneumonia Treatment Drugs Business (2016-2021) & (US$ Million) Table 87. Johnson and Johnson Recent Development Table 88. Teva Pharmaceutical Company Details Table 89. Teva Pharmaceutical Business Overview Table 90. Teva Pharmaceutical Viral Pneumonia Treatment Drugs Product Table 91. Teva Pharmaceutical Revenue in Viral Pneumonia Treatment Drugs Business (2016-2021) & (US$ Million) Table 92. Teva Pharmaceutical Recent Development Table 93. Research Programs/Design for This Report Table 94. Key Data Information from Secondary Sources Table 95. Key Data Information from Primary Sources List of Figures Figure 1. Global Viral Pneumonia Treatment Drugs Market Share by Type: 2020 VS 2027 Figure 2. Ribavirin Features Figure 3. Acyclovir Features Figure 4. Ganciclovir Features Figure 5. Others Features Figure 6. Global Viral Pneumonia Treatment Drugs Market Share by Application: 2020 VS 2027 Figure 7. Hospital Pharmacies Case Studies Figure 8. Retail Pharmacies Case Studies Figure 9. Online Pharmacies Case Studies Figure 10. Others Case Studies Figure 11. Viral Pneumonia Treatment Drugs Report Years Considered Figure 12. Global Viral Pneumonia Treatment Drugs Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 13. Global Viral Pneumonia Treatment Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 14. Global Viral Pneumonia Treatment Drugs Market Share by Regions: 2020 VS 2027 Figure 15. Global Viral Pneumonia Treatment Drugs Market Share by Regions (2022-2027) Figure 16. Global Viral Pneumonia Treatment Drugs Market Share by Players in 2020 Figure 17. Global Top Viral Pneumonia Treatment Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Viral Pneumonia Treatment Drugs as of 2020 Figure 18. The Top 10 and 5 Players Market Share by Viral Pneumonia Treatment Drugs Revenue in 2020 Figure 19. Global Viral Pneumonia Treatment Drugs Revenue Market Share by Type (2016-2021) Figure 20. Global Viral Pneumonia Treatment Drugs Revenue Market Share by Type (2022-2027) Figure 21. North America Viral Pneumonia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 22. North America Viral Pneumonia Treatment Drugs Market Share by Type (2016-2027) Figure 23. North America Viral Pneumonia Treatment Drugs Market Share by Application (2016-2027) Figure 24. North America Viral Pneumonia Treatment Drugs Market Share by Country (2016-2027) Figure 25. United States Viral Pneumonia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Canada Viral Pneumonia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Viral Pneumonia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. Europe Viral Pneumonia Treatment Drugs Market Share by Type (2016-2027) Figure 29. Europe Viral Pneumonia Treatment Drugs Market Share by Application (2016-2027) Figure 30. Europe Viral Pneumonia Treatment Drugs Market Share by Country (2016-2027) Figure 31. Germany Viral Pneumonia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. France Viral Pneumonia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. U.K. Viral Pneumonia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Italy Viral Pneumonia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Russia Viral Pneumonia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Nordic Viral Pneumonia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Viral Pneumonia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Asia-Pacific Viral Pneumonia Treatment Drugs Market Share by Type (2016-2027) Figure 39. Asia-Pacific Viral Pneumonia Treatment Drugs Market Share by Application (2016-2027) Figure 40. Asia-Pacific Viral Pneumonia Treatment Drugs Market Share by Region (2016-2027) Figure 41. China Viral Pneumonia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Japan Viral Pneumonia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. South Korea Viral Pneumonia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Southeast Asia Viral Pneumonia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. India Viral Pneumonia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Australia Viral Pneumonia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Viral Pneumonia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Latin America Viral Pneumonia Treatment Drugs Market Share by Type (2016-2027) Figure 49. Latin America Viral Pneumonia Treatment Drugs Market Share by Application (2016-2027) Figure 50. Latin America Viral Pneumonia Treatment Drugs Market Share by Country (2016-2027) Figure 51. Mexico Viral Pneumonia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Brazil Viral Pneumonia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Viral Pneumonia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Middle East & Africa Viral Pneumonia Treatment Drugs Market Share by Type (2016-2027) Figure 55. Middle East & Africa Viral Pneumonia Treatment Drugs Market Share by Application (2016-2027) Figure 56. Middle East & Africa Viral Pneumonia Treatment Drugs Market Share by Country (2016-2027) Figure 57. Turkey Viral Pneumonia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Saudi Arabia Viral Pneumonia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. UAE Viral Pneumonia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. Roche Revenue Growth Rate in Viral Pneumonia Treatment Drugs Business (2016-2021) Figure 61. GlaxoSmithKline Revenue Growth Rate in Viral Pneumonia Treatment Drugs Business (2016-2021) Figure 62. Pfizer Revenue Growth Rate in Viral Pneumonia Treatment Drugs Business (2016-2021) Figure 63. Novartis Revenue Growth Rate in Viral Pneumonia Treatment Drugs Business (2016-2021) Figure 64. Johnson and Johnson Revenue Growth Rate in Viral Pneumonia Treatment Drugs Business (2016-2021) Figure 65. Teva Pharmaceutical Revenue Growth Rate in Viral Pneumonia Treatment Drugs Business (2016-2021) Figure 66. Bottom-up and Top-down Approaches for This Report Figure 67. Data Triangulation Figure 68. Key Executives Interviewed

Roche GlaxoSmithKline Pfizer Novartis Johnson and Johnson Teva Pharmaceutical